PALRX
Price
$18.25
Change
-$0.00 (-0.00%)
Updated
Jul 18 closing price
Net Assets
1.01B
RLBBX
Price
$36.55
Change
-$0.03 (-0.08%)
Updated
Jul 18 closing price
Net Assets
252.37B
Interact to see
Advertisement

PALRX vs RLBBX

Header iconPALRX vs RLBBX Comparison
Open Charts PALRX vs RLBBXBanner chart's image
PGIM Balanced R
Price$18.25
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.01B
American Funds American Balanced R2
Price$36.55
Change-$0.03 (-0.08%)
VolumeN/A
Net Assets252.37B
PALRX vs RLBBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PALRX vs. RLBBX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PALRX is a StrongBuy and RLBBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 252B vs. PALRX (1.01B). PALRX pays higher dividends than RLBBX: PALRX (1.66) vs RLBBX (1.17). PALRX was incepted earlier than RLBBX: PALRX (21 years) vs RLBBX (23 years). PALRX (27.98) is less costly to investors than RLBBX (1.32). PALRX is a more actively managed with annual turnover of: 107.00 vs. RLBBX (44.00). PALRX has a lower initial minimum investment than RLBBX: PALRX (0) vs RLBBX (250). RLBBX annual gain was more profitable for investors over the last year : 6.25 vs. PALRX (2.29). RLBBX return over 5 years is better than : 34.69 vs. PALRX (22.70).
PALRXRLBBXPALRX / RLBBX
Total Expense Ratio1.471.32111%
Annual Report Gross Expense Ratio27.981.322,120%
Fund Existence21 years23 years-
Gain YTD6.0687.70379%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.01B252B0%
Annual Yield % from dividends1.661.17142%
Returns for 1 year2.296.2537%
Returns for 3 years29.7933.4589%
Returns for 5 years22.7034.6965%
Returns for 10 years30.1555.4154%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHV2.750.06
+2.23%
Achieve Life Sciences
LIXT3.780.06
+1.61%
Lixte Biotechnology Holdings
DORM122.401.08
+0.89%
Dorman Products
ALNT39.47N/A
N/A
Allient
SMMT27.63-0.64
-2.26%
Summit Therapeutics